title: The primary care physician's role in the monitoring and management of the potential sequelae of the medical treatment of prostate cancer: early and late.
abstract: Significant progress has been made in the management of aggressive prostate cancer. The established old and new treatments have resulted in the significant delay in progression of disease, improvement of the quality of life, as well as the increase in the overall survival of men with advanced prostate cancer. However, these therapies carry with them possible adverse effects that primary care physicians are experienced in managing. Thus, there is an increasing need for the urologist to involve and partner closely with the primary care practitioner to prevent, identify and manage the potential side effects of these life-changing therapies.
authors.affiliation: Division of Urology, Department of Surgery at Mackenzie Health, Richmond Hill, Ontario, Canada.
authors.forename: Victor
authors.initials: V
authors.lastname: Mak
authors.forename: Jack
authors.initials: J
authors.lastname: Barkin
mesh_terms: D000069501:Abiraterone Acetate / Q000009:adverse effects; D000726:Androgen Antagonists / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D000069448:Denosumab / Q000009:adverse effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000009:adverse effects / Q000031:analogs & derivatives; D058007:Physicians, Primary Care; D024382:Professional Role; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D011868:Radioisotopes / Q000009:adverse effects; D011883:Radium / Q000009:adverse effects; D013997:Time Factors
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D011868:Radioisotopes; D010669:Phenylthiohydantoin; D000069448:Denosumab; C540278:enzalutamide; D000069501:Abiraterone Acetate; C581106:radium Ra 223 dichloride; D011883:Radium